28,877 Shares in Merit Medical Systems, Inc. $MMSI Bought by Van Hulzen Asset Management LLC

Key Points

• Van Hulzen Asset Management bought 28,877 shares of Merit Medical Systems in the second quarter, valued at approximately $2.0 million. Institutional investors and hedge funds collectively own 99.66% of the company.
• Merit Medical exceeded quarterly expectations, reporting $1.19 in EPS versus the $0.96 consensus and revenue of $418.84 million, up 9.5% year over year. The company issued fiscal 2026 EPS guidance of $4.25–$4.35.
• Analyst sentiment remains positive, with eight Buy ratings and four Holds producing a “Moderate Buy” consensus and an average price target of $100.

Van Hulzen Asset Management LLC acquired a new stake in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 28,877 shares of the medical instruments supplier's stock, valued at approximately $2,002,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Bessemer Group Inc. lifted its stake in Merit Medical Systems by 54.2% in the 4th quarter. Bessemer Group Inc. now owns 313,981 shares of the medical instruments supplier's stock valued at $27,674,000 after acquiring an additional 110,392 shares in the last quarter. WINTON GROUP Ltd bought a new position in shares of Merit Medical Systems during the 4th quarter worth approximately $12,239,000. Trillium Asset Management LLC bought a new position in shares of Merit Medical Systems during the 2nd quarter worth approximately $6,105,000. Norges Bank acquired a new stake in shares of Merit Medical Systems in the fourth quarter valued at approximately $75,957,000. Finally, Quantinno Capital Management LP raised its holdings in shares of Merit Medical Systems by 200.3% in the first quarter. Quantinno Capital Management LP now owns 17,612 shares of the medical instruments supplier's stock valued at $1,214,000 after purchasing an additional 11,747 shares during the last quarter. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Price Performance

NASDAQ:MMSI opened at $90.28 on Tuesday. The stock has a market capitalization of $5.39 billion, a PE ratio of 37.31, a P/E/G ratio of 2.28 and a beta of 0.48. Merit Medical Systems, Inc. has a 1-year low of $59.74 and a 1-year high of $94.75. The firm has a fifty day simple moving average of $77.88 and a 200 day simple moving average of $72.58. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The company's quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, research analysts expect that Merit Medical Systems, Inc. will post 3.81 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on MMSI. JPMorgan Chase & Co. raised their target price on shares of Merit Medical Systems from $77.00 to $95.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. Piper Sandler increased their price objective on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an "overweight" rating in a research note on Friday, July 31st. Canaccord Genuity Group increased their price objective on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a report on Friday, July 31st. Finally, Wells Fargo & Company lifted their target price on Merit Medical Systems from $74.00 to $83.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Eight research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Merit Medical Systems currently has an average rating of "Moderate Buy" and a consensus target price of $100.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source